Endo International plc - Articles and news items

Endo to acquire Par Pharmaceutical in a transaction valued at $8.05 billion

Industry news / 18 May 2015 /

Endo is set to acquire privately-held Par Pharmaceutical in a transaction valued at $8.05 billion. The acquisition will expand Endo’s generics business…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+